Generics BulletinSun signaled launch action ahead in the US and a change in plan for certain pipeline specialty assets, even as it awaits, like other industry peers , more clarity on details around US President Don
ScripSun signaled launch action ahead in the US and a change in plan for certain pipeline specialty assets, even as it awaits, like other industry peers , more clarity on details around US President Don
ScripUS President Donald Trump’s ever-evolving stance on tariffs may be rattling the world and also has pharma on tenterhooks, but going down that path for generic medicines may be a doubled-edged sword or
Pink SheetUS President Donald Trump has announced a general 26% reciprocal tariff on India, but a country-agnostic exemption of categories like pharmaceuticals implies that Indian pharma firms will not be direc